Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB26FDT88
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,512
Award facts
- Contract value 100% obligated
- $13,512.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,512.23 to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of RINVOQ ER 15 MG tablets (30-count units). This firm fixed-price delivery order, which is non-set-aside and competitively awarded, will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of October 28, 2025. RINVOQ is a prescription medication used in the treatment of rheumatoid arthritis and other inflammatory conditions, representing one of many pharmaceutical products that AmerisourceBergen delivers through its federal contract portfolio.
This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive pharmaceutical prime vendor contract enables AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military and federal healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen leverages this prime vendor vehicle to efficiently fulfill both routine and specialized pharmaceutical requirements across the Department of Defense and other federal healthcare programs.
Quick answers
Who was awarded contract SPE2DB26FDT88?
SPE2DB26FDT88 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FDT88 worth?
The government has obligated $13,512 on SPE2DB26FDT88.
Is contract SPE2DB26FDT88 an order under another contract?
Yes. SPE2DB26FDT88 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB26FDT88 competed?
The extent of competition for SPE2DB26FDT88 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award